Glaxo To Stop Paying Doctors To Promote Drugs

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/251833628/251833642" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

The head of British drug maker GlaxoSmithKline told The New York Times on Monday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences — a practice criticized as a conflict of interest.

LINDA WERTHEIMER, HOST:

NPR's business news starts with new rules for Glaxo.

(SOUNDBITE OF MUSIC)

WERTHEIMER: The head of British - the British drug maker GlaxoSmithKline, told The New York Times yesterday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences - a practice criticized as a conflict of interest.

Glaxo's CEO told the company - told the paper - the company would also stop paying all its sales reps based on how many prescriptions doctors write.

Copyright © 2013 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR’s programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.